ACAN Oblitoxaximab injection

Buyer
Department of Public Works and Government Services (PSPC)
Location
National
Category
Healthcare & Medical
Published
November 17, 2026
Closes
December 8, 2026, 9:00 AM ET (15 days left)

View the official notice

Supplier guide: how to register on CanadaBuys

Description

Advanced Contract Award Notice(ACAN) - Oblitoxaximab Injection

An ACAN is a public notice indicating to the supplier community that a department or agency intends to award a contract for goods, services or construction to a pre-identified supplier, thereby allowing other suppliers to signal their interest in bidding, by submitting a statement of capabilities. If no supplier submits a statement of capabilities that meets the requirements set out in the ACAN, on or before the closing date stated in the ACAN, the contracting officer may then proceed with the award to the pre identified supplier.

Purpose of this Advanced Contract Award Notice (ACAN):

Public Services and Procurement Canada proposes to negotiate a contract with Elusys Therapeutics, Inc on behalf of Public Health Agency of Canada (PHAC).

Requirement description:

Public Health Agency of Canada (PHAC) has a requirement for Oblitoxaximab injection, an antitoxin used to treat inhalation anthrax.

Get alerts for tenders like this

Free account. Keyword alerts by email.

Buyer activity

Tenders this buyer posted in the last 12 months: 2,016

Other open tenders from this buyer

Related tenders

Contains information licensed under the Open Government Licence – Canada. View licence · About our data sources